KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Assets Average: 2018-2024

Historic Assets Average for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Dec 2024 value amounting to $3.5 billion.

  • Amneal Pharmaceuticals' Assets Average rose 0.74% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year increase of 0.74%. This contributed to the annual value of $3.5 billion for FY2024, which is 4.10% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Assets Average stood at $3.5 billion for FY2024, which was down 4.10% from $3.6 billion recorded in FY2023.
  • Amneal Pharmaceuticals' 5-year Assets Average high stood at $4.0 billion for FY2021, and its period low was $3.5 billion during FY2024.
  • Moreover, its 3-year median value for Assets Average was $3.6 billion (2023), whereas its average is $3.7 billion.
  • Its Assets Average has fluctuated over the past 5 years, first rose by 3.57% in 2021, then declined by 6.04% in 2023.
  • Over the past 5 years, Amneal Pharmaceuticals' Assets Average (Yearly) stood at $3.8 billion in 2020, then increased by 3.57% to $4.0 billion in 2021, then fell by 2.60% to $3.9 billion in 2022, then dropped by 6.04% to $3.6 billion in 2023, then decreased by 4.10% to $3.5 billion in 2024.